Rachel Davies is not able to access the life-extending drug because she lives in Wales.
Bristol Myers Squibb on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended expanded approval of its Augtyro cancer drug in a pair of indications.
In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
Known for its traditional health benefits, this remarkable fungus may hold the key to slowing cancer progression, according ...
University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...
The drug redirects the immune system to find and target specific mutations and gene changes that are only found in cancer ...
The UChicago Medicine team will be led by Odunsi as co-principal investigator and includes Christopher Weber, Savas Tay, and ...
These findings could pave the way for new treatment approaches for cancers driven by RAS mutations. Researchers at the ...
Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to a new editorial.
Researchers at Uppsala University and KTH Royal Institute of Technology have created an antibody that has the potential to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback